The items listed below should be considered by the Meeting in 2006 and 2007. The compounds listed include those recommended as priorities by the CCPR at its 36th and earlier sessions and compounds scheduled for re-evaluation within the CCPR periodic review programme.
2007 JMPR
|
Toxicological evaluations |
Residue evaluations |
|
| |
|
|
|
New compounds |
New compounds |
|
|
Dimethomorph |
Dimethomorph |
|
|
Pyrimethanil |
Pyrimethanil |
|
| Zoxamide | Zoxamide | |
| Difenoconazole | Difenoconazole | |
| |
|
|
|
Periodic re-evaluations |
Periodic re-evaluations |
|
|
Azinphos-methyl (002) |
Benalaxyl (155) |
|
|
l-Cyhalothrin |
Clofentezine (156) |
|
|
Flusilazole (165) |
Cyfluthrin and b-cyfluthrin (157) |
|
|
Procymidone (136) |
Cyromazine (169) |
|
|
Profenofos (171) |
Flusilazole (165) |
|
|
Vinclozolin (159) |
Permethrin (120) |
|
| |
Profenofos (171) |
|
| |
Propiconazole (160) |
|
| |
|
|
|
Evaluations |
Evaluations |
|
|
Fenitrothion - review of acute and chronic toxicity |
Tebuconazole |
|
|
Carbaryl - review of basis for ARfD setting |
Carbaryl - review of alternate GAP |
|
2008 JMPR
|
Toxicological evaluations |
Residue evaluations |
|
|
|
|
New compounds |
New compounds |
|
|
|
|
Periodic re-evaluations |
Periodic re-evaluations |
|
Bioresmethrin (93) |
Azinphos-methyl (002) |
|
Buprofezin (173) |
l-Cyhalothrin |
|
Chlorpyrifos-methyl (090) |
Procymidone (136) |
|
Hexythiazox (176) |
|
